Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q2- Text added to 2020 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
bad, cabozantinib, clearance, corruption, delete, detailed, EEA, hacking, hematologic, imputed, inadequacy, incidence, landscape, lapse, malware, mild, monotherapy, Neoleukin, noncompliant, opt, Pandion, pecuniary, phishing, priming, prompted, randomized, safeguarding, scrutiny, store, transmit, ulcerative, viability, viral
Removed:
commencement, ipilimumab, month, replaced, triplet, Yervoy
Valuein 2020 Q2 filing- Value in 2020 Q3 filing
Original filings
Filing view